Clinical trials

2

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

OM336 in Seropositive Autoimmune Diseases

An early-phase clinical trial evaluating the safety, tolerability, and pharmacokinetics of OM336 in adult participants with seropositive autoimmune diseases. OM336 is administered subcutaneously in ascending dose cohorts.

Participants needed: 39
Trial details
Phase: Phase 1Age: 18-75Biological sex: AllType: InterventionalSponsor: Ouro MedicinesUpdated: Jun 15, 2026Locations: 1
Eligibility criteria

Diagnosis of active seropositive autoimmune disease [+3]

Previous treatment with a BCMA-targeted therapy [+3]

Status: Recruiting

OM336 in Autoimmune Cytopenias

An early-phase clinical trial evaluating the safety, tolerability, and pharmacokinetics of subcutaneously dosed OM336 in adult participants with autoimmune cytopenias.

Participants needed: 32
Trial details
Phase: Phase 1Age: 18-75Biological sex: AllType: InterventionalSponsor: Ouro MedicinesUpdated: Sep 30, 2025Locations: 3
Eligibility criteria

Active autoimmune cytopenia [+3]

Previous treatment with a BCMA-targeted therapy [+3]